Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Clinical trial NCT03276832 · COMPLETED

Trial details

NCT number: NCT03276832
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7

Start date: 2017-12-20
Primary completion: 2019-10-15
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.